Ho Robert 4
4 · Neoleukin Therapeutics, Inc. · Filed Aug 12, 2020
Insider Transaction Report
Form 4
Ho Robert
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-08-10+90,000→ 90,000 totalExercise: $12.00Exp: 2030-08-10→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the total shares on August 10, 2021, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.